The case for biosimilars

Dr Kolberg speaks with ecancer at ESMO 2018 in Munich about the medical and economic case for wider use of biosimilars in cancer care. For more on the ESMO symposium on biosimilars, watch interviews with Prof Diana Lüftner and Dr Arnold Vulto. ecancer offers a CME accredited e-learning module on biosimilars, available through ecancer.org.